移动医疗技术在慢性透析患者管理中的干预和评估:范围综述。

Intervention and Evaluation of Mobile Health Technologies in Management of Patients Undergoing Chronic Dialysis: Scoping Review.

机构信息

School of Public Health and Health Systems, Faculty of Applied Health Sciences, University of Waterloo, Waterloo, ON, Canada.

出版信息

JMIR Mhealth Uhealth. 2020 Apr 3;8(4):e15549. doi: 10.2196/15549.

Abstract

BACKGROUND

Studies have shown the effectiveness and user acceptance of mobile health (mHealth) technologies in managing patients with chronic kidney disease (CKD). However, incorporating mHealth technology into the standard care of patients with CKD still faces many challenges. To our knowledge, there are no reviews on mHealth interventions and their assessments concerning the management of patients undergoing dialysis.

OBJECTIVE

This study provided a scoping review on existing apps and interventions of mHealth technologies in adult patients undergoing chronic dialysis and identified the gaps in patient outcome assessment of mHealth technologies in the literature.

METHODS

We systematically searched PubMed (MEDLINE), Scopus, and the Cumulative Index to Nursing and Allied Health Literature databases, as well as gray literature sources. Two keywords, "mHealth" and "dialysis," were combined to address the main concepts of the objectives. Inclusion criteria were as follows: (1) mHealth interventions, which are on a smartphone, tablet, or web-based portals that are accessible through mobile devices; and (2) adult patients (age ≥18 years) on chronic dialysis. Only English papers published from January 2008 to October 2018 were included. Studies with mHealth apps for other chronic conditions, based on e-consultation or videoconferencing, non-English publications, and review papers were excluded.

RESULTS

Of the 1054 papers identified, 22 met the inclusion and exclusion criteria. Most studies (n=20) were randomized controlled trials and cohort studies. These studies were carried out in 7 countries. The main purposes of these mHealth interventions were as follows: nutrition or dietary self-monitoring (n=7), remote biometric monitoring (n=7), web-based portal (n=4), self-monitoring of in-session dialysis-specific information (n=3), and self-monitoring of lifestyle or behavioral change (n=1). The outcomes of the 22 included studies were organized into five categories: (1) patient satisfaction and acceptance, (2) clinical effectiveness, (3) economic assessment, (4) health-related quality of life, and (5) impact on lifestyle or behavioral change. The mHealth interventions showed neutral to positive results in chronic dialysis patient management, reporting no to significant improvement of dialysis-specific measurements and some components of the overall quality of life assessment. Evaluation of these mHealth interventions consistently demonstrated evidence in patients' satisfaction, high level of user acceptance, and reduced use of health resources and cost savings to health care services. However, there is a lack of studies evaluating safety, organizational, sociocultural, ethical, and legal aspects of mHealth technologies. Furthermore, a comprehensive cost-effectiveness and cost-benefit analysis of adopting mHealth technologies was not found in the literature.

CONCLUSIONS

The gaps identified in this study will inform the creation of health policies and organizational support for mHealth implementation in patients undergoing dialysis. The findings of this review will inform the development of a comprehensive service model that utilizes mHealth technologies for home monitoring and self-management of patients undergoing chronic dialysis.

摘要

背景

研究表明,移动医疗(mHealth)技术在管理慢性肾脏病(CKD)患者方面的有效性和用户接受度。然而,将 mHealth 技术纳入 CKD 患者的标准护理仍然面临许多挑战。据我们所知,目前尚无关于 mHealth 干预措施及其对接受透析治疗的患者管理评估的综述。

目的

本研究对接受慢性透析的成年患者使用的 mHealth 技术的现有应用程序和干预措施进行了范围界定综述,并确定了文献中 mHealth 技术在患者结果评估方面的差距。

方法

我们系统地检索了 PubMed(医学文献在线数据库)、Scopus 和 Cumulative Index to Nursing and Allied Health Literature 数据库以及灰色文献来源。使用“mHealth”和“dialysis”这两个关键词来解决目标的主要概念。纳入标准如下:(1)mHealth 干预措施,指可通过移动设备访问的智能手机、平板电脑或基于网络的门户;(2)接受慢性透析的成年患者(年龄≥18 岁)。仅纳入 2008 年 1 月至 2018 年 10 月发表的英文论文。排除基于电子咨询或视频会议、非英文出版物和综述论文的用于其他慢性疾病的 mHealth 应用程序的研究。

结果

在 1054 篇论文中,有 22 篇符合纳入和排除标准。大多数研究(n=20)为随机对照试验和队列研究。这些研究在 7 个国家进行。这些 mHealth 干预措施的主要目的如下:营养或饮食自我监测(n=7)、远程生物计量监测(n=7)、基于网络的门户(n=4)、会话内透析特定信息的自我监测(n=3)和生活方式或行为改变的自我监测(n=1)。22 项纳入研究的结果分为以下五类:(1)患者满意度和接受度,(2)临床效果,(3)经济评估,(4)健康相关生活质量,(5)对生活方式或行为改变的影响。mHealth 干预措施在慢性透析患者管理中显示出中性至积极的结果,报告透析特定测量值无显著改善或某些整体生活质量评估的组成部分有所改善。对这些 mHealth 干预措施的评估一致表明患者满意度高、用户接受度高、减少卫生资源使用和节省医疗保健服务成本。然而,目前缺乏关于 mHealth 技术的安全性、组织、社会文化、伦理和法律方面的评估研究。此外,文献中也没有发现采用 mHealth 技术的综合成本效益和成本效益分析。

结论

本研究中发现的差距将为制定卫生政策和为透析患者实施 mHealth 提供组织支持。本综述的结果将为利用 mHealth 技术进行慢性透析患者家庭监测和自我管理的综合服务模式的开发提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b1d/7165304/de2a01aa8fda/mhealth_v8i4e15549_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索